Amphastar Pharmaceuticals Total Non Current Liabilities 2011-2026 | AMPH

Annual Total Non Current Liabilities Amphastar Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	69.4 M	42.4 M	50.1 M	37.9 M	34.7 M	44.9 M	21.8 M	24 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
69.4 M	21.8 M	40.6 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Precigen PGEN	261 M	$ 3.1	-0.96 %	$ 758 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	101 M	$ 220.9	2.49 %	$ 5 B	Danmark
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.33	0.76 %	$ 339 M	Britain
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
ProQR Therapeutics N.V. PRQR	31.9 M	$ 1.58	6.04 %	$ 99.5 M	Niderland
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	21.2 M	-	-	$ 789 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Corbus Pharmaceuticals Holdings CRBP	25.1 M	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	70.2 M	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.53	5.1 %	$ 868 M	Canada
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
CytomX Therapeutics CTMX	228 M	$ 4.22	-0.47 %	$ 582 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Cyclacel Pharmaceuticals CYCC	1.06 M	-	-5.98 %	$ 34.1 M	USA